CU Cancer Center Associate Director of Basic Research, Heide Ford, PhD, leads research on inhibiting EYA phosphatases, which are crucial to cancer growth and metastasis through MYC deregulation and immune suppression. While her lab has seen progress targeting EYA2 in aggressive brain cancer, addressing EYA3 in breast cancer remains a challenge.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045